v3.25.2
STOCKHOLDERS' EQUITY - Schedule of Non-vested Share Activity (Details) - $ / shares
3 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Grant Date Weighted Average Fair Value (per share)    
Granted (in usd per share) $ 11,414 $ 60
Number of shares converted from RSU (in share) 1  
Percentage of convertible RSU payable in stock 50.00%  
Percentage of convertible RSU payable in cash 50.00%  
Restricted stock | Restricted Stock Grants (2022 Plan)    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, [Roll Forward]    
Beginning balance (in shares) 49,261 39,409
Granted (in shares) 0 9,852
Vested (in shares) 0 0
Forfeited (in shares) 0 0
Ending balance (in shares) 49,261 49,261
Restricted Stock Units (Manager Plan) | Restricted Stock Units (Manager Plan)    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, [Roll Forward]    
Beginning balance (in shares) 2,611,361 2,611,361
Granted (in shares) 2,186,565 0
Vested (in shares) (364,378) 0
Forfeited (in shares) 0 0
Ending balance (in shares) 4,433,548 2,611,361